iShares突破性環境解決方案ETF ETEC 深 滬
已收盤 11-06 16:00:00 美东时间
22.6148
+0.435
+1.96%
華盛通- 最 高22.6148
- 今 開22.5411
- 成交量 3954股
- 最 低 22.45
- 昨 收 22.1799
- 總市值 361.84万
- 52周最高 32.3041
- 市盈率 靜 --
- 換手率 2.47%
- 52周最低 21.51
- 委 比 -20.00%
- 總股本 16.00万
- 歷史最高 32.3041
- 量 比 2.82
- 振 幅 0.74%
- 歷史最低 15.5384
- 每 手 1
- 風險率 2.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aldoro, WILLETECH Agree Strategic Kameelburg Partnership
Aldoro Resources Ltd. ( ($AU:ARN) ) has provided an update. Aldoro Resources is...
11-05 07:15
Immuron continued quarterly sales growth
Immuron Limited reported Q1 FY27 sales growth of 9% globally, with strong performance in Australia (+14%), Canada (+286%), and weaker results in the U.S. (-19%). Australia's growth was driven by Travelan® brand relaunch and increased market penetration. The U.S. decline was attributed to inventory challenges, but future sales are expected to improve. Canada's surge was due to brand awareness efforts. Travelan® continues to gain market share in ph...
10-27 10:00
Travelan® Phase 2 Study Results Published
Immuron Limited announced the publication of Phase 2 clinical trial data for Travelan® in *Scientific Reports*. The study showed a statistically significant 50% reduction in ETEC-related adverse events compared to placebo, despite not meeting the primary efficacy endpoints due to a lower-than-expected placebo attack rate. Key findings included reductions in diarrhea severity and early antibiotic use, supporting Travelan's potential protective ben...
10-13 10:00
VolitionRx prepays $7.5M senior secured convertible note in full
VolitionRx (VNRX) said on Monday it prepaid in full the outstanding balance of its $7.5M senior secured convertible promissory note issued to Lind Global Asset Management. Following the prepayment, al...
09-14 20:58
Epiminder Hits Key Enrolment Milestone in U.S. Epilepsy Study
Epiminder Ltd. ( ($AU:EPI) ) has shared an announcement. Epiminder has reached ...
06-01 07:18
